Full Year 2022 H Lundbeck A/S Earnings Call Transcript
Welcome to the Lundbeck Financial Statements for the full year 2022. (Operator Instructions) Today, I'm pleased to present Deborah Dunsire, President and CEO; Joerg Hornstein, Executive Vice President and CFO; and Johan Luthman, Executive Vice President of Research and Development.
Speakers, please begin.
/-&
Hello, everyone, and welcome to the financial update for 2022 for Lundbeck. You see here one of our patients, the people who we serve every day, living with migraine. Next slide, please. The forward-looking statements, you've seen before, so I won't dwell on them because I'd far prefer to turn to the next slide and say we had an outstanding year at Lundbeck and achieved the highest ever revenue for the company in its history.
Revenue was up 12%, and our strategic brands, which are really the engine driving that growth were up in aggregate 31%. Vyepti, the newest of the strategic brands grew 104% and the strategic brands are now approximately
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |